Shari Redstone, chair of Paramount Global, was diagnosed with thyroid cancer earlier this spring, as confirmed by her spokesperson. After experiencing fatigue and other symptoms, she sought medical attention approximately two months ago and received her diagnosis the following day. Surgeons operated to remove her thyroid gland, but some cancer cells had already spread to her vocal cords. Despite this challenging health situation, Redstone is continuing all her professional and philanthropic activities as she undergoes ongoing treatment. Her spokesperson stated that Redstone is grateful for her excellent prognosis.
The news of Redstone’s diagnosis was kept private and shared only with a small group of family, close friends, and advisers, including David Ellison, the head of Skydance, whose company is poised to acquire Paramount and the Redstone family’s stake. This disclosure comes during a significant time for the company, as Paramount is preparing for an $8.4 billion merger with Skydance Media, which still awaits approval from the U.S. FCC.
Additionally, Paramount is involved in mediation concerning a lawsuit filed by former President Donald Trump against CBS, reportedly offering $15 million to settle the matter. Redstone’s health issues and the company’s strategic moves closely intertwine, as she navigates her condition while potentially reshaping the future of Paramount amidst these high-stakes business developments.
Note: The image is for illustrative purposes only and is not the original image of the presented article.
